China’s First Medical Devices Innovation Base To Set Up In Chongqing
This article was originally published in PharmAsia News
China's Ministry of Science and Technology has reached an agreement with Chongqing municipal government to set up an independent national innovation industry base for medical devices. The facility will focus on common problems in the industry by building up a public service platform for fast innovation design, new technology development and application, as well as experimental technology standards. It will also conduct industry, national and international research. After five years, the base is targeted to achieve breakthrough in industrialized core technologies for 50 projects and realize a production value of RMB 50 billion. Chongqing has an edge in independent R&D and innovation within the digital health sector, having developed the world's first high-intensity focused ultrasound tumor therapy system and Asia's first gastrointestinal capsule endoscopy. (Click here for more - Chinese Language)
You may also be interested in...
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Following the announcement in the US that ranitidine drugs must be withdrawn from the market, the European Medicines Agency told the Pink Sheet it would decide on the fate of these medicines in the EU after wrapping up its own inquiry.
Alvogen believes it is the first company to file for a generic pazopanib rival to Novartis’ Votrient oncology brand in Europe.